CUPERTINO, Calif., Feb. 4 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that Matthew J. Hogan, Chief Financial Officer,
will be presenting at the BIO CEO and Investor Conference to be held at the
Waldorf Astoria Hotel in New York on February 11, 2008 at 11:45 a.m. Eastern
Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)
A live audio webcast of the presentation will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations”.
If you are unable to participate during the live webcast, the call will be
archived on DURECT’s website under Audio Archive in the “Investor Relations”
section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit
http://www.www.durect.com.
SOURCE DURECT Corporation
02/04/2008
CONTACT: Matthew J. Hogan, Chief Financial Officer of DURECT
Corporation, +1-408-777-4936
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.www.durect.com